The stock of Iovance Biotherapeutics Inc (NASDAQ:IOVA) last traded at $3.87, up 1.31% from the previous session.
Data from the available sources indicates that Iovance Biotherapeutics Inc (NASDAQ:IOVA) is covered by 13 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $38.00 and a low of $14.00, we find $20.00. Given the previous closing price of $3.82, this indicates a potential upside of 423.56 percent. IOVA stock price is now -19.04% away from the 50-day moving average and -40.90% away from the 200-day moving average. The market capitalization of the company currently stands at $958.91M.
In total, 1 analysts have assigned it a hold rating, and 10 have given it a buy rating. Brokers who have rated the stock have averaged $22.36 as their price target over the next twelve months.
With the price target reduced from $40 to $18, Barclays maintained Overweight rating for Iovance Biotherapeutics Inc (NASDAQ: IOVA).
In other news, MCPEAK MERRILL A, Director bought 10,000 shares of the company’s stock on Sep 18. The stock was bought for $55,600 at an average price of $5.56. Upon completion of the transaction, the Director now directly owns 248,633 shares in the company, valued at $0.96 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 15, Director Rothbaum Wayne P. bought 5,000,000 shares of the business’s stock. A total of $26,500,000 was incurred on buying the stock at an average price of $5.30. This leaves the insider owning 23,067,333 shares of the company worth $89.27 million. A total of 19.31% of the company’s stock is owned by insiders.
With an opening price of $3.8400 on Wednesday morning, Iovance Biotherapeutics Inc (NASDAQ: IOVA) set off the trading day. During the past 12 months, Iovance Biotherapeutics Inc has had a low of $3.21 and a high of $9.61. As of last week, the company has a debt-to-equity ratio of 0.14, a current ratio of 3.10, and a quick ratio of 2.99. The fifty day moving average price for IOVA is $4.7802 and a two-hundred day moving average price translates $6.5479 for the stock.
The latest earnings results from Iovance Biotherapeutics Inc (NASDAQ: IOVA) was released for Jun, 2023. According to the Biotechnology Company, earnings per share came in at -$0.47, beating analysts’ expectations of -$0.8 by 0.33. This compares to -$0.63 EPS in the same period last year. The net profit margin was -175981.09% and return on equity was -79.68% for IOVA. For the current quarter, analysts expect IOVA to generate $4.19M in revenue.
